<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>667</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15213142</PubmedId>
            <Abstract>Immunity to Entamoeba species intestinal infection is associated with the presence of intestinal IgA antibodies against the parasite's galactose-inhibitable adherence lectin. We determined the epitope specificity of serum and intestinal antilectin IgA antibodies by enzyme-linked immunosorbent assay using overlapping fragments of a recombinant portion of the lectin heavy subunit, designated LC3. These findings were correlated with the effects of epitope-specific murine antilectin immunoglobulin A (IgA) monoclonal antibodies (MAbs) on amebic in vitro galactose-specific adherence. LC3 is a highly antigenic and immunogenic cysteine-rich protein (amino acids [aa] 758 to 1150) that includes the lectin's carbohydrate binding domain. The study subjects, from Durban, South Africa, were recently cured of amebic liver abscess (ALA) with or without concurrent Entamoeba histolytica intestinal infection or were infection free 1 year after cure. We also studied seropositive subjects that were infected with E. histolytica, disease free, and asymptomatic. Serum anti-LC3 IgA antibodies from all study groups exclusively recognized the third (aa 868 to 944) and the seventh (aa 1114 to 1134) LC3 epitopes regardless of clinical status; epitope 6 (aa 1070 to 1114) was also recognized by serum anti-LC3 IgG antibodies. However, IgG antibody recognition of epitope 6 but not 3 or 7 was lost 1 year following cure of ALA. We produced 14 murine anti-LC3 IgA MAbs which collectively recognized five of the seven LC3 epitopes. The majority of the murine MAbs recognized the first epitope (aa 758 to 826), which was not recognized by human IgA antibodies. Interestingly, adherence of E. histolytica trophozoites to CHO cells was inhibited by MAbs against epitopes 1, 3, 4 (aa 944 to 987), and 6 (P &lt; 0.01). The LC3 epitopes recognized by human IgA antibodies (3 and 7) were further characterized by use of overlapping synthetic peptides. We identified four peptides (aa 891 to 903, 918 to 936, 1114 to 1134, and 1128 to 1150) that in linear or cyclized form were recognized by pooled intestinal IgA antibodies and serum IgG antibodies from subjects with ALA and asymptomatic, seropositive infected subjects. This study identifies the lectin epitopes to be studied in an amebiasis subunit vaccine designed to elicit mucosal immunity mimicking that of humans cured of ALA.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>3974-80</ArticlePages>
            <ArticleTitle>Identification of the Entamoeba histolytica galactose-inhibitable lectin epitopes recognized by human immunoglobulin A antibodies following cure of amebic liver abscess.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Abd-Alla</LastName>
                    <ForeName>Mohamed D</ForeName>
                </Author>
                <Author>
                    <LastName>Jackson</LastName>
                    <ForeName>Terry F G H</ForeName>
                </Author>
                <Author>
                    <LastName>Soong</LastName>
                    <ForeName>Ginny C</ForeName>
                </Author>
                <Author>
                    <LastName>Mazanec</LastName>
                    <ForeName>Mary</ForeName>
                </Author>
                <Author>
                    <LastName>Ravdin</LastName>
                    <ForeName>Jonathan I</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Medicine, University of Minnesota, 516 Delaware Street, MMC 194, PWB 14-110, Minneapolis, MN, USA. ravdi001@umn.edu.</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Epitopes;Immunoglobulin A;Immunoglobulin G;Lectins;Microtubule-Associated Proteins;light chain 3, human;Galactose</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Antibodies, Monoclonal(immunology); CHO Cells(immunology); Cell Adhesion(immunology); Cricetinae; Entamoeba histolytica(immunology); Epitopes(immunology); Galactose(metabolism); Humans; Immunoglobulin A(immunology); Immunoglobulin G(immunology); Lectins(immunology; metabolism); Liver Abscess, Amebic(immunology); Microtubule-Associated Proteins(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>72</Volume>
                <Issue>7</Issue>
                <Title>Infection and immunity</Title>
                <Issn>0019-9567</Issn>
                <MedlineTa>Infect Immun</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>LC3 peptide 2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CTYEITTRECKTC</LinearSequence>
                        <StartingPosition>898</StartingPosition>
                        <EndingPosition>910</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P32022.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5759</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Results section</LocationOfData>
                <EpitopeId>7245</EpitopeId>
                <ReferenceStartingPosition>891</ReferenceStartingPosition>
                <ReferenceEndingPosition>903</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>6450</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5759</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>LC3 peptide 2</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Sera and stool samples were obtained from seropositive subjects from several possible disease states:  asymptomatic infection, recently cured of ALA, and ALA patients 1 year after cure.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>50</ResponseFrequency>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-LC3 Ab</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgA</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>LC3 peptide 2</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CTYEITTRECKTC</LinearSequence>
                                        <StartingPosition>898</StartingPosition>
                                        <EndingPosition>910</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P32022.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5759</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>LC3 peptide 9</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CAEETKNGGVPFKCKNN</LinearSequence>
                        <StartingPosition>925</StartingPosition>
                        <EndingPosition>941</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P32022.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5759</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Results section</LocationOfData>
                <EpitopeId>5972</EpitopeId>
                <ReferenceStartingPosition>918</ReferenceStartingPosition>
                <ReferenceEndingPosition>939</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>A cysteine was added to the C-terminal end of the peptide.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>6451</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5759</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>LC3 peptide 9</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Sera and stool samples were obtained from seropositive subjects from several possible disease states:  asymptomatic infection, recently cured of ALA, and ALA patients 1 year after cure.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>66.7</ResponseFrequency>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-LC3 Ab</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgA</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>LC3 peptide 9</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CAEETKNGGVPFKCKNN</LinearSequence>
                                        <StartingPosition>925</StartingPosition>
                                        <EndingPosition>941</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P32022.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5759</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>LC3 peptide 11</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CDQTTGETIYTKKTCTVSEEF</LinearSequence>
                        <StartingPosition>1129</StartingPosition>
                        <EndingPosition>1149</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P23502.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5759</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Results section</LocationOfData>
                <EpitopeId>6135</EpitopeId>
                <ReferenceStartingPosition>1114</ReferenceStartingPosition>
                <ReferenceEndingPosition>1138</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>6497</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5759</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Sera and stool samples were obtained from seropositive subjects from several possible disease states:  asymptomatic infection, recently cured of ALA, and ALA patients 1 year after cure.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>16.7</ResponseFrequency>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-LC3 Ab</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgA</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>LC3 peptide 11</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CDQTTGETIYTKKTCTVSEEF</LinearSequence>
                                        <StartingPosition>1129</StartingPosition>
                                        <EndingPosition>1149</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P23502.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5759</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>LC3 peptide 12</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CTVSEEFPTITPNQGRCFYCQCS</LinearSequence>
                        <StartingPosition>1143</StartingPosition>
                        <EndingPosition>1165</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P23502.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5759</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Results section</LocationOfData>
                <EpitopeId>7242</EpitopeId>
                <ReferenceStartingPosition>1128</ReferenceStartingPosition>
                <ReferenceEndingPosition>1150</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>7511</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5759</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Sera and stool samples were obtained from seropositive subjects from several possible disease states:  asymptomatic infection, recently cured of ALA, and ALA patients 1 year after cure.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>66.7</ResponseFrequency>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-LC3 Ab</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgA</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>LC3 peptide 12</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CTVSEEFPTITPNQGRCFYCQCS</LinearSequence>
                                        <StartingPosition>1143</StartingPosition>
                                        <EndingPosition>1165</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P23502.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5759</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

